Ohio-based startup Deep Lens has raised $14 million in series A funding, bringing its total raised to $17.5 million. The company will use the financing to further develop its precision medicine software suite and fuel a fresh round of hiring in its service, sales, and marketing divisions.
Northpond Ventures led the series A round, joined by existing investors Rev1 Ventures, Sierra Ventures, and Tamarind-Hill Partners. The foundation of Deep Lens’ toolkit is VIPER: Virtual Imaging Pathology for Education and Research, a full-stack AI image detection suite with feedback tools, cloud storage, and APIs for integration with hardware and apps. VIPER can flag patients eligible for clinical trials at the time of their diagnosis, with the goal of providing better patient outcomes and clinical research.
“Since our inception, we’ve benefited from a tremendous group of investors, which now includes the world class team at Northpond Ventures,” CEO and co-founder Dave Billiter said in a press release. “This series A financing is further validation of the value of our industry-changing approach to digital pathology in delivering the right cancer diagnoses faster and accelerating oncology trial recruitment and timelines.”
- 360 Dx: Deep Lens Closes $14M Series A Round to Advance Digital AI Pathology Platform
- MedCity News: Deep Lens wraps up $14M Series A round to improve digital pathology platform
- Medgadget: Deep Lens Raises $14 million to Improve AI-driven Pathology (Interview)
- VentureBeat: Deep Lens raises $14 million to improve clinical trial recruitment with AI